Early adopters come together to dialog with the makers of the Quell wearable technology. WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) held its first Quell ® Wearable Pain Relief Technology™ user event last Thursday, April 27 . As a customer-focused company, NeuroMetrix
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported today that Notices of Allowance has been issued for patents covering key technological features of the Company's Quell ® Wearable Pain Relief Technology™ by the European Patent Office , the Japan Patent Office, and the
Shares of Common Stock and Certain Warrants Will Begin Trading on a Split-Adjusted Basis on May 12, 2017 BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced a one-for-eight reverse split of its common stock effective as of Thursday, May 11, 2017 .
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that researchers from the University of Rochester School of Medicine and Dentistry will present a scientific poster titled "Wearable TENs band for chemotherapy-induced peripheral neuropathy (CIPN): A feasibility
Blog to serve as a resource on issues and topics related to chronic pain, such as digital medicine and alternative treatments WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc . (Nasdaq: NURO) today announced the launch of LivingQuell , a blog that will serve as an online resource for people
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq:NURO) announced that it was the recipient of the Smaller Businesses Association of New England (SBANE) New England Innovation Award for the development and successful launch of Quell ® Wearable Pain Relief Technology™.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,656,070. The patent covers the novel application of real-time accelerometer measurements to control transcutaneous electrical nerve stimulation.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO) today announced that Shai N. Gozani M.D., Ph.D., President and CEO of NeuroMetrix , is scheduled to speak at the upcoming LD Micro Invitational at the Luxe Sunset Bel Air Hotel in Los Angeles, CA. Dr.
Waltham -based company to exhibit its wearable device for widespread chronic pain relief BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) is showing Quell ® , its 100% drug-free Wearable Pain Relief Technology™ to sleep medicine professionals from around the world at SLEEP 2017 , the
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO) today announced that Shai N. Gozani M.D., Ph.D., President and CEO of NeuroMetrix , is scheduled to speak at the upcoming 2017 Marcum Microcap Conference at the Grand Hyatt Hotel in New York City. Dr.